Three|Weekly Cisplatin Superior to Weekly Dose in Head and Neck ...

Weekly Low‐Dose Versus Three‐Weekly High‐Dose Cisplatin for ...

The level of evidence for the use of weekly cisplatin chemoradiation in locally advanced squamous cell carcinoma of the head and neck is limited.

The evidence on effectiveness of weekly vs triweekly cisplatin ...

While some have proposed that low-dose weekly cisplatin is safer and less toxic, this study emphasized that there is no difference in acute toxicity of the two ...

Three-Weekly Cisplatin Superior to Weekly Dose in Head and Neck ...

Three-weekly cisplatin is superior to a weekly dose in preventing locoregional relapse when combined with radiotherapy in head and neck ...

Weekly Cisplatin Plus Radiation for Postoperative Head and Neck ...

Chemoradiotherapy with 3-weekly cisplatin at a dose of 100 mg/m2 is the standard treatment for patients with postoperative locally advanced ...

Three Weekly Versus Weekly Cisplatin: Comparison of two Different ...

Introduction: Chemoradiotherapy (CRT) with concurrent cisplatin-based chemotherapy is the treatment of choice of locally advanced head and ...

3-weekly or weekly cisplatin concurrently with radiotherapy for ...

Concurrent chemoradiotherapy with cisplatin is standard for patients (pts) with loco-regionally advanced squamous cell carcinoma of the head ...

Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent ...

Concurrent chemoradiotherapy is an established component of the nonoperative management of locally advanced head and neck squamous cell ...

Comparing High-Dose Cisplatin Every Three Weeks to Low-Dose ...

To determine whether radiation with low-dose cisplatin weekly is superior in terms of acute toxicity, as measured by the T-scores (TAME method), ...

Phase III randomized trial comparing weekly versus three-weekly ...

Background: Chemoradiation (CRT) with cisplatin 100mg/m2 given 3-weekly is the standard of care in locally advanced head and neck squamous ...

Concurrent chemoradiotherapy with cisplatin given once-a-week ...

National Comprehensive Cancer Network (NCCN) guidelines version 2.2022 for head and neck cancers [19] recommends high-dose three-weekly cisplatin as the ...

Long-Term Update of a Phase 3 Randomized Study Comparing ...

In the weekly-3-weekly study, cisplatin at 100 mg/m2 once-every-3-weeks led to superior locoregional control compared with cisplatin 30 mg/m2 ...

Comparing High- and Low-Dose Cisplatin for Patients with ...

The Phase II portion of this trial will determine whether radiation therapy combined with weekly low-dose cisplatin is superior to high-dose ...

Is it acceptable to give weekly cisplatin for patients with - theMednet

Recently published data suggests that weekly cisplatin 30 mg/m2 is inferior to high dose cisplatin (1). In a randomized phase III trial comparing high dose ...

High-Dose Three-Weekly or Low-Dose Weekly Cisplatin during ...

In locally advanced squamous cell carcinoma of the head and neck, adding three cycles of high-dose (100 mg/m2) cisplatin every three weeks ...

Standard versus fractionated high-dose cisplatin plus radiation for ...

Chemoradiotherapy with high-dose cisplatin (HD-Cis: 100 mg/m2 q3w for three cycles) is the standard of care (SOC) in locally advanced head and neck squamous ...

Optimal regimen of cisplatin in squamous cell carcinoma of head ...

Those data collected from retrospective cohorts showed that cisplatin 40 mg/m2 weekly is a promising regimen with potential comparable efficacy to 100 mg every ...

Concurrent Chemoradiation Therapy With Weekly Cisplatin for ...

When combined with radiotherapy as definitive treatment of locally advanced head and neck squamous cell carcinoma, cisplatin at a dose of 40 ...

Less Frequent Cisplatin Superior in Head, Neck Cancer - Medscape

A higher dose of cisplatin given once every 3 weeks provided better locoregional control than a lower weekly dose in patients with locally ...

Comparison of weekly administration of cisplatin versus three ...

squamous cell carcinoma of the head-and-neck. Seventy-five patients receiving radiochemotherapy with weekly cisplatin (30–40 mg/m2) were ...

Audiological Outcomes of Weekly vs. Triweekly Cisplatin in Head ...

Recent data from randomized phase 3 studies showed that weekly cisplatin has the same oncological outcomes as high-dose triweekly cisplatin when combined with ...